12 results
PRE 14A
IMPLQ
Impel Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:11pm
, diversity and personal skills in life sciences and biotechnology, finance, marketing, financial reporting and other areas that are expected … Committee considers director tenure. We value diversity on a company-wide basis but have not adopted a specific policy regarding Board diversity
DEF 14A
IMPLQ
Impel Pharmaceuticals Inc
26 Apr 22
Definitive proxy
4:16pm
and characteristics of directors, including such factors as business experience, diversity and personal skills in life sciences and biotechnology, finance … recommendations for nomination for reelection, the Nominating and Governance Committee considers director tenure. We value diversity on a company-wide basis
10-K
2021 FY
IMPLQ
Impel Pharmaceuticals Inc
29 Mar 22
Annual report
5:09pm
bargaining agreements, and we believe our relationship with our employees is good.
Diversity and Inclusion
We are committed to creating and maintaining
424B4
IMPLQ
Impel Pharmaceuticals Inc
10 Sep 21
Prospectus supplement with pricing info
4:01pm
with our employees is good.
Diversity and Inclusion
We are committed to creating and maintaining a workplace free from discrimination or harassment
DRS
x8nda xqe44mxd6o
25 Aug 21
Draft registration statement
12:00am
424B1
lrgdnip
23 Apr 21
Prospectus with pricing info
4:01pm
S-1
jenkihy6udc d5n2w9f4
2 Apr 21
IPO registration
3:04pm
DRS/A
1bnnbo
23 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next